01 4Rabipur/RabAvert
Main Therapeutic Indication : Vaccine
Currency : USD
2020 Revenue in Millions : 101
2019 Revenue in Millions : 0
Growth (%) : Buyed from GSK
Main Therapeutic Indication : Vaccine
Currency : USD
2021 Revenue in Millions : 77
2020 Revenue in Millions : 100
Growth (%) : -19
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 126
2021 Revenue in Millions : 77
Growth (%) : 63
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 169
2022 Revenue in Millions : 126
Growth (%) : 32
